A Study To Evaluate The Efficacy Of Eplerenone Compared With Losartan For The Treatment Of Patients With Mild To Moderate Hypertension

NCT00649311 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

248

Enrollment

INDUSTRY

Sponsor class

Stopped Poor enrollment; termination not due to safety reasons.

Conditions

Hypertension

Interventions

DRUG: eplerenone
DRUG: Losartan

Sponsor

Pfizer